What's in Novartis Gene Therapies's pipeline?

Novartis Gene Therapies has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Novartis Gene Therapies's portfolio?

Top competitors by shared drug class: Abeona Therapeutics, Inc, AskBio Inc, BioLab 612 LLC, Brain Neurotherapy Bio, Inc., Emily de los Reyes.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/novartis-gene-therapies.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Novartis Gene Therapies — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Novartis Gene Therapies pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Onasemnogene Abeparvovec-xioi	Onasemnogene Abeparvovec-xioi	marketed	Gene therapy	SMN1 gene	Neurology

Therapeutic area mix

Neurology · 1
Rare Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Abeona Therapeutics, Inc · 1 shared drug class
AskBio Inc · 1 shared drug class
BioLab 612 LLC · 1 shared drug class
Brain Neurotherapy Bio, Inc. · 1 shared drug class
Emily de los Reyes · 1 shared drug class
Eva Morava-Kozicz · 1 shared drug class
Kolon TissueGene, Inc. · 1 shared drug class
4D Molecular Therapeutics · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Novartis Gene Therapies:

Cite this brief

Drug Landscape (2026). Novartis Gene Therapies — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/novartis-gene-therapies. Accessed 2026-05-17.